Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jasmin Schelhaas"'
Autor:
Lourens T. Bloem, Jasmin Schelhaas, Lucía López‐Anglada, Carla Herberts, Paula B. van Hennik, Olli Tenhunen
Since 2006, the European conditional marketing authorization (CMA) aims to facilitate timely patient access to medicinal products for which there is an unmet medical need by accepting less comprehensive data than normally required. The granting of CM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4135e212be33e6200812c4b1f281a967
https://dspace.library.uu.nl/handle/1874/429487
https://dspace.library.uu.nl/handle/1874/429487
Autor:
Tobias B. Polak, David G. J. Cucchi, Jasmin Schelhaas, Syed S. Ahmed, Naima Khoshnaw, Joost van Rosmalen, Carin A. Uyl-de Groot
Publikováno v:
Polak, T B, Cucchi, D G J, Schelhaas, J, Ahmed, S S, Khoshnaw, N, van Rosmalen, J & Uyl-de Groot, C A 2023, ' Results from Expanded Access Programs : A Review of Academic Literature ', Drugs, vol. 83, no. 9, pp. 795-805 . https://doi.org/10.1007/s40265-023-01879-4
Background: Although expanded access is an increasingly used pathway for patients to access investigational medicine, little is known on the magnitude and content of published scientific research collected via expanded access. Methods: We performed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a1f425627735d19b80b40ebd4668c76
https://doi.org/10.1007/s40265-023-01879-4
https://doi.org/10.1007/s40265-023-01879-4
